Bellevue Asset Management (Switzerland)’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	$3.68M	Hold	65,000	–	–	0.56%	57
2015 Q3	$2.59M	Hold	65,000	–	–	0.42%	74
2015 Q2	$3.1M	Buy	65,000 +25,000	+63%	+$1.19M	0.43%	71
2015 Q1	$1.59M	Buy	+40,000	New	+$1.59M	0.22%	101